biomarker

  1. SNT Gatchaman

    Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with ... post-acute sequelae of SARS-CoV-2, 2023, B. Hanson et al

    Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection Hanson; Visvabharathy; Orban; Jimenez; Batra; Liotta; DeLisle; Klausner; Cohen; Padhye; Tachas; Koralnik Persistent symptoms of COVID-19...
  2. Andy

    Trial Report Possible Markers For Myalgic Encephalomyelitis / CFS Developed In Long Covid: Utility Of Serum Ferritin And Insulin-like Growth Factor-I,2023,Yamamoto

    Merged thread Final paper abstract here ************ Editorial: Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome? Coronavirus disease 2019 (COVID-19) has provoked a catastrophic medical emergency worldwide...
  3. SNT Gatchaman

    2023 IIMEC15 - Alain Moreau

    YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023 Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps — 9:07 MicroRNAs 18:18 SMPDL3B 27:03 FGF-21 SMPDL3B is Sphingomyelin...
  4. SNT Gatchaman

    Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Epidemiology, Pathogenesis..., 2023, Tsilingiris et al

    Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges Tsilingiris, Dimitrios; Vallianou, Natalia G.; Karampela, Irene; Christodoulatos, Gerasimos Socrates; Papavasileiou, Georgios; Petropoulou...
  5. C

    Protocol Development of a digital biomarker and intervention for subclinical depression: study protocol for a longitudinal waitlist control study, 2023, Teepe

    Development of a digital biomarker and intervention for subclinical depression: study protocol for a longitudinal waitlist control study Gisbert W. Teepe, Yanick X. Lukic, Birgit Kleim, Nicholas C. Jacobson, Fabian Schneider, Prabhakaran Santhanam, Elgar Fleisch & Tobias Kowatsch Abstract...
  6. Wyva

    Review Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review, 2023, Maksoud et al

    Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifaceted condition that affects most body systems. There is currently no known diagnostic biomarker; instead, diagnosis is dependent on application of symptom-based case criteria following exclusion of any...
  7. SNT Gatchaman

    The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis, 2021, Kimber-Trojnar et al.

    The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis Kimber-Trojnar, Żaneta; Pilszyk, Aleksandra; Niebrzydowska, Magdalena; Pilszyk, Zuzanna; Ruszała, Monika; Leszczyńska-Gorzelak, Bożena Endometriosis is a disease that affects women of...
  8. cassava7

    Medical conditions that are well recognized but that (currently) lack a diagnostic biomarker?

    As the title asks. “Well recognized” means that the diagnosis is uncontroversial in conventional medicine. The obvious one is Alzheimer’s but there may be other such syndromes and diseases. If considered to be neurological diseases, or at least primarily biological in nature, this applies to...
  9. ahimsa

    WebMD: Researchers Hunt Biomarkers – Potential Keys to Long COVID

    WebMD: Researchers Hunt Biomarkers – Potential Keys to Long COVID https://www.webmd.com/covid/news/20230106/researchers-hunt-long-covid-biomarkers Brief mention of ME/CFS:
  10. SNT Gatchaman

    Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations, 2022, Bonetto et al

    Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C...
  11. Sly Saint

    Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism 2022, Patel et al

    Abstract Background Long-COVID is characterized by prolonged, diffuse symptoms months after acute COVID-19. Accurate diagnosis and targeted therapies for Long-COVID are lacking. We investigated vascular transformation biomarkers in Long-COVID patients. Methods A case–control study utilizing...
  12. SNT Gatchaman

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome, 2022, Gravelsina et al

    Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome Gravelsina Sabine, Vilmane Anda, Svirskis Simons, Rasa-Dzelzkaleja Santa, Nora-Krukle Zaiga, Vecvagare Katrine, Krumina Angelika, Leineman Iana, Shoenfeld Yehuda, Murovska Modra Myalgic...
  13. Snow Leopard

    The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue, Pifarré et al, 2022

    The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue Fernando Pifarréa, Lluís Rossellób, Raúl Hilenoc, Joan Palmic, Llúcia Bañeresc, Antoni Planasc, Joan Antoni Prat Abstract Background The aim of this study was to verify whether the mean percentage of...
  14. Andy

    Diagnosis of [ME/CFS] With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles, 2022, González-Cebrián et al

    Full title: Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic disease characterized by long-lasting persistent...
  15. Mij

    Submax Exercise Provokes Activation of the Anterior Default Mode Network During the Resting State as a Biomarker of PEM in ME/CFS, Rayhan, 2021

    Original title: Submaximal Exercise Provokes Increased Activation of the Anterior Default Mode Network During the Resting State as a Biomarker of Postexertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Rakib U. Rayhan et al Abstract Background: Myalgic...
  16. Hoopoe

    The maintained attention assessment in patients affected by [ME/CFS]: a reliable biomarker?, Murga et al, 2021

    Conclusion General cognition remains preserved in most patients, only a small group of them shows a significant mild cognitive impairment. Maintained attention is clearly deficient, showing a marked fatigability after the Toulouse-Piéron test. The effort was perceived as very hard by both...
  17. Wyva

    Saliva fatigue biomarker index as a marker for severe ME/CFS in a community based sample, 2021, Jason et al

    ABSTRACT Objective The prevalence of pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) has been estimated from an ethnically and sociodemographically diverse community-based random sample of 10,119 youth aged 5–17. We assessed whether a salivary biomarker of fatigue could...
  18. Sly Saint

    Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Subtyping, 2021, Castro-Marrero et al

    Abstract Background: Routine blood analytics are systematically used in the clinic to diagnose disease or confirm individuals’ healthy status. For myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disease relying exclusively on clinical symptoms for its diagnosis, blood analytics...
  19. Sly Saint

    Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), 2021, Gravelsina et al

    Abstract Reliable serum biomarkers are of immense need for diagnostic purposes of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a disabling and complex disease for which diagnosis is mainly based on clinical symptoms. The aim of this study was to evaluate a possible diagnostic...
  20. Andy

    The mapping of cortical activation by near-infrared spectroscopy might be a biomarker related to the severity of [FM] symptoms, 2021, Donadel et al

    Full title: The mapping of cortical activation by near-infrared spectroscopy might be a biomarker related to the severity of fibromyalgia symptoms Abstract The delta value of oxyhemoglobin (Δ-HbO) determined by functional near-infrared spectroscopy at prefrontal cortex (PFC) and motor cortex...
Back
Top Bottom